
Epilim 500mg (Sodium Valproate) in Kenya
KSh 7,080.00
Epilim 500mg contains sodium valproate, an anticonvulsant and mood stabilizer used to treat epilepsy (focal/generalized seizures), bipolar disorder, and migraine prevention. It works by increasing GABA levels in the brain, stabilizing electrical activity. Available as enteric-coated tablets in Kenya, it requires strict medical supervision due to significant risks.
Product Description
Overview
Epilim 500mg contains sodium valproate, an anticonvulsant and mood stabilizer used to treat epilepsy (focal/generalized seizures), bipolar disorder, and migraine prevention. It works by increasing GABA levels in the brain, stabilizing electrical activity. Available as enteric-coated tablets in Kenya, it requires strict medical supervision due to significant risks.
Composition
- Active Ingredient: Sodium valproate 500mg per tablet.
- Form: White, enteric-coated, oval tablets (prevents stomach irritation).
- Inactive Ingredients: Colloidal silica, hypromellose, magnesium stearate, titanium dioxide.
Side Effects
Common
- Gastrointestinal: Nausea, diarrhea, abdominal pain, indigestion.
- Neurological: Tremor, drowsiness, dizziness, hair loss.
- Weight Gain: Due to increased appetite.
Serious Risks
- Hepatotoxicity:
- Symptoms: Jaundice, dark urine, fatigue (risk highest in first 6 months).
- Action: Stop immediately; monitor liver enzymes (ALT/AST).
- Pancreatitis:
- Symptoms: Severe abdominal pain, vomiting.
- Action: Discontinue and hospitalize.
- Teratogenicity:
- Pregnancy: Causes neural tube defects (e.g., spina bifida).
- Action: Avoid in women of childbearing age unless no alternatives.
- Blood Disorders: Thrombocytopenia (low platelets), anemia.
- Hyperammonemia: Encephalopathy (confusion, lethargy).
How to Use
- Dosage:
- Epilepsy: Start 600mg/day; increase to 1,000–2,000mg/day in 2 divided doses.
- Bipolar Disorder: 750mg/day; max 2,000mg/day.
- Migraine Prevention: 500mg twice daily.
- Administration:
- Take with food to reduce GI upset.
- Swallow whole; do not crush/chew (enteric coating).
- Monitoring:
- Liver Function: ALT/AST at baseline, then monthly for 6 months.
- Blood Counts: CBC at baseline, then every 3 months.
- Ammonia Levels: If encephalopathy suspected.
- Precautions:
- Avoid if: Liver disease, pancreatitis history, mitochondrial disorders.
- Pregnancy: Contraindicated (use lamotrigine/levetiracetam instead).
- Drug Interactions:
- Avoid with: Carbapenem antibiotics (reduce valproate levels).
- Caution with: Lamotrigine (increases lamotrigine levels), aspirin (increases free valproate).
Frequently Asked Questions
-
Is Epilim 500mg available over-the-counter?
No – prescription-only by neurologists/psychiatrists. -
Does NHIF cover it?
Partially – covered for epilepsy/bipolar disorder under chronic illness scheme (co-payment required). -
Can it be used for children?
Yes – dose adjusted by weight (e.g., 20–30mg/kg/day). -
What if liver enzymes rise?
Stop immediately and consult a doctor; may need alternative therapy. -
Are there cheaper alternatives?
Yes – sodium valproate generics (KES 50–150/tablet) or carbamazepine (KES 20–50/tablet). -
Is it safe during breastfeeding?
Caution – excreted in milk; monitor infant for drowsiness/poor feeding. -
How long does one pack last?
10–30 days (1–2 tablets/day).
Conclusion
Epilim 500mg remains a first-line treatment for epilepsy and bipolar disorder in Kenya due to its efficacy and affordability (KES 150–300/tablet). However, its use demands rigorous monitoring for hepatotoxicity, pancreatitis, and teratogenicity. While NHIF coverage improves access, rural stockouts and specialist shortages persist. For women of childbearing age, alternative therapies (e.g., lamotrigine) are strongly preferred. Despite newer anticonvulsants, sodium valproate’s broad-spectrum efficacy ensures its continued role in Kenyan neurology/psychiatry, provided risks are managed through vigilant lab monitoring and patient education. Always prioritize liver safety and pregnancy prevention in treatment plans.



Reviews
There are no reviews yet.